Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel treatment options for lipoprotein disorders described in recent patent literature

May 27, 2008

Elaprase approved in Brazil

May 27, 2008

New data on pasireotide activity in bronchial carcinoids, acromegaly presented

May 27, 2008

Synthetic Blood International obtains exclusive license to VCU discoveries

May 26, 2008

Novo Nordisk files for regulatory approval of liraglutide in the U.S. and Europe

May 26, 2008

FDA issues approvable letter for bazedoxifene in postmenopausal osteoporosis

May 26, 2008

Enclomiphene increases testosterone in men with adult idiopathic hyogonadotrophic hypogonadism

May 23, 2008

Recent patents report new therapeutic agents for obesity and lipoprotein disorders

May 22, 2008

Novel treatments for diabetes described in recent patent literature

May 22, 2008

Merck & Co. discontinues ACHIEVE imaging study of MK-0524A in HeFH

May 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...